Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Cookie preferences
Back to Industry News
General

Bico Chairman Rolf Claesson Resigns; Maria Rankka Named Interim Successor

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Dagens industri
general related image for: Bico Chairman Rolf Claesson Resigns; Maria Rankka Named Interim Successor

Photo by Mina Rad on Unsplash

Key takeaways

  • Dagens Industri reports that Rolf Claesson, Chairman of the Board at medical technology company Bico, has resigned from his position for health reasons
  • Claesson, who recently celebrated his 80th birthday and served as chairman for just over two years, was noted for his strong criticism of the company's former CEO and founder during his tenure
  • Following Claesson's departure, the Bico board has appointed board member Maria Rankka as interim successor
Dagens Industri reports that Rolf Claesson, Chairman of the Board at medical technology company Bico, has resigned from his position for health reasons. Claesson, who recently celebrated his 80th birthday and served as chairman for just over two years, was noted for his strong criticism of the company's former CEO and founder during his tenure. Following Claesson's departure, the Bico board has appointed board member Maria Rankka as interim successor. Rankka, who is 30 years younger than Claesson, will temporarily assume the role of chairman. This appointment serves as a transitional measure, with a permanent chairman to be elected at the company's general meeting. No further details regarding the timeline for a permanent replacement or the specific nature of Claesson's health issues were disclosed. This leadership change represents a significant transition for the medical technology firm.

Related Topics

BicoRolf ClaessonMaria RankkaChairmanLeadership TransitionMedical Technology

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original